Eli Lilly Wins FDA Approval for Once-Weekly Onswik Insulin
Indianapolis, Indiana, U.S., September 24, 2026 Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Indianapolis, Indiana, U.S., September 24, 2026 Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval...
HONG KONG, Aug 27, 2026 Akeso, Inc. announced its 2026 interim results, reporting record commercial drug sales while advancing...
San Francisco, California, August 20, 2026 Chai Discovery has announced a collaboration with Bristol Myers Squibb (BMS) to advance...
Emeryville, California, August 17, 2026 OmniAb, Inc. has announced a new global collaboration and license agreement with Eli Lilly...
Bedford, Massachusetts, August 14, 2026 Lantheus Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...
San Diego, California, August 14, 2026 BioSapien Inc., a biotechnology company developing localized drug-delivery technologies for cancer treatment, has...
Boston, Massachusetts, August 11, 2026 Rhythm Pharmaceuticals announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA)...
PITTSBURGH, July 29, 2026 Viatris Inc. has received U.S. Food and Drug Administration (FDA) approval for Gwyn Loâ„¢ (norelgestromin...
LONDON, July 30, 2026 GSK has reported strong Q2 2026 financial results, driven by continued growth across its Specialty...
Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...
